Update on the diagnosis of severe asthma in children and adolescents

Abstract

Severe pediatric asthma is a very challenging type of asthma for both physicians and patients. Precision medicine in severe pediatric asthma has undergone important developments in recent years. This therapeutic approach requires an adequate diagnosis and clinical phenotyping of patients and is useful for predicting the prognosis and response to treatment in this type of patient. This article summarizes the scientific information of the last five years in the diagnosis of severe pediatric asthma, focusing on topics such as genetic markers, biomarkers, lung function, radiological techniques, and bronchoscopy.

Keywords

Severe asthma / diagnosis / children / adolescents

References

[1] Rutter CE, Silverwood RJ, Pearce N, Strachan DP ; Global Asthma Network Study Group. Potential asthma risk factors do not account for global asthma symptom prevalence patterns and time trends in children and adolescents. World Allergy Organ J. 2024; 17: 100917.

[2] Pijnenburg MW, Fleming L. Advances in understanding and reducing the burden of severe asthma in children. Lancet Respir Med. 2020; 8: 1032-44.

[3] Carr TF. The Lifelong Burden of Severe Childhood Asthma. Chest. 2024; 166: 653-4.

[4] Manti S, Magri P, De Silvestri A, De Filippo M, Votto M, Marseglia GL, et al. Epidemiology of severe asthma in children: a systematic review and meta-analysis. Eur Respir Rev. 2024; 33: 240095.

[5] Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014; 43: 343-73.

[6] Global Strategy for Asthma Management and Prevention [Internet]. Global Initiative for Asthma; c2024 [cited 2024 Nov 29]. Available from: https://ginasthma.org/2024-report/

[7] Scotney E, Burchett S, Goddard T, Saglani S. Pediatric problematic severe asthma: Recent advances in management. Pediatr Allergy Immunol. 2021; 32: 1405-15.

[8] Cheng DT, Wee LYJ, Teoh OH, Thomas B. Approach to difficult-to-treat asthma in childhood: a narrative review. Singapore Med J. 2024.

[9] Zhou X, Zhang P, Tan H, Dong B, Jing Z, Wu H, et al. Progress in diagnosis and treatment of difficult-to-treat asthma in children. Ther Adv Respir Dis. 2023; 17: 17534666231213637.

[10] Mahmood L, Keskin S, Jefferson AA. Precision care in the treatment of pediatric asthma. Curr Opin Pediatr. 2024; 36: 304-9.

[11] Nieto-García A, Nieto-Cid M, Mazón-Ramos Á. Biological treatments in childhood asthma. Curr Opin Allergy Clin Immunol. 2024; 24: 114-21.

[12] Hernandez-Pacheco N, Pino-Yanes M, Flores C. Genomic Predictors of Asthma Phenotypes and Treatment Response. Front Pediatr. 2019; 7: 6.

[13] Yan Q, Forno E, Herrera-Luis E, Pino-Yanes M, Qi C, Rios R, et al. A genome-wide association study of severe asthma exacerbations in Latino children and adolescents. Eur Respir J. 2021; 57: 2002693.

[14] Herrera-Luis E, Mak ACY, Perez-Garcia J, Martin-Gonzalez E, Eng C, Beckman KB, et al. Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth. Thorax. 2023; 78: 233-41.

[15] Herrera-Luis E, Espuela-Ortiz A, Lorenzo-Diaz F, Keys KL, Mak ACY, Eng C, et al. Genome-wide association study reveals a novel locus for asthma with severe exacerbations in diverse populations. Pediatr Allergy Immunol. 2021; 32: 106-15.

[16] Eliasen AU, Pedersen CET, Rasmussen MA, Wang N, Soverini M, Fritz A, et al. Genome-wide study of early and severe childhood asthma identifies interaction between CDHR3 and GSDMB . J Allergy Clin Immunol. 2022; 150: 622-30.

[17] Wolters AAB, Kersten ETG, Koppelman GH. Genetics of preschool wheeze and its progression to childhood asthma. Pediatr Allergy Immunol. 2024; 35: e14067.

[18] Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, et al. A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. Pharmacogenomics J. 2019; 19: 249-59.

[19] Joo J, Mak ACY, Xiao S, Sleiman PM, Hu D, Huntsman S, et al. Genome-wide association study in minority children with asthma implicates DNAH5 in bronchodilator responsiveness . Sci Rep. 2022; 12: 12514.

[20] Dahlin A, Sordillo JE, McGeachie M, Kelly RS, Tantisira KG, Lutz SM, et al. Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma. PLoS One. 2020; 15: e0229241.

[21] Goleva E, Babineau DC, Gill MA, Jackson LP, Shao B, Hu Z, et al. Expression of corticosteroid-regulated genes by PBMCs in children with asthma. J Allergy Clin Immunol. 2019; 143: 940-7.e6.

[22] Zhang M, Han Y. MicroRNAs in chronic pediatric diseases (Review). Exp Ther Med. 2024; 27: 100.

[23] Liu X, Gao J, Yang L, Yuan X. Roles of Exosomal miRNAs in Asthma: Mechanisms and Applications. J Asthma Allergy. 2024; 17: 935-47.

[24] Hernandez-Pacheco N, Vijverberg SJ, Herrera-Luis E, Li J, Sio YY, Granell R, et al. Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use. Eur Respir J. 2021; 57: 2003388.

[25] Sharma R, Tiwari A, Kho AT, Celedón JC, Weiss ST, Tantisira KG, et al. Systems Genomics Reveals microRNA Regulation of ICS Response in Childhood Asthma. Cells. 2023; 12: 1505.

[26] Ong MS, Sordillo JE, Dahlin A, McGeachie M, Tantisira K, Wang AL, et al. Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in Asthma. J Pers Med. 2024; 14: 246.

[27] Sharma R, Tiwari A, Kho AT, Wang AL, Srivastava U, Piparia S, et al. Circulating microRNAs associated with bronchodilator response in childhood asthma. BMC Pulm Med. 2024; 24: 553.

[28] Wong R, Desai B, Sharma R, Srivastava U, Kho AT, Weiss ST, et al. Identification of MicroRNAs in children with increased asthma bronchodilator usage in genetics of asthma in Costa Rica Study. Pediatr Pulmonol. 2024; 59: 3491-8.

[29] Tiwari A, Hobbs BD, Li J, Kho AT, Amr S, Celedón JC, et al. Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD. Noncoding RNA. 2022; 8: 27.

[30] Eldosoky MA, Hammad R, Rushdi A, Ibrahim HF, Tawfeik AM, Mora A, et al. MicroRNA-146a-5p and microRNA-210-3p Correlate with T Regulatory Cells Frequency and Predict Asthma Severity in Egyptian Pediatric Population. J Asthma Allergy. 2023; 16: 107-21.

[31] Akhter T, Mileti E, Kere MM, Kolmert J, Konradsen JR, Hedlin G, et al. Enhancers regulate genes linked to severe and mild childhood asthma. Heliyon. 2024; 10: e34386.

[32] Perez-Garcia J, Herrera-Luis E, Li A, Mak ACY, Huntsman S, Oh SS, et al. Multi-omic approach associates blood methylome with bronchodilator drug response in pediatric asthma. J Allergy Clin Immunol. 2023; 151: 1503-12.

[33] Perez-Garcia J, Pino-Yanes M, Plender EG, Everman JL, Eng C, Jackson ND, et al. Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells. Clin Epigenetics. 2023; 15: 156.

[34] Martin-Almeida M, Perez-Garcia J, Herrera-Luis E, Rosa-Baez C, Gorenjak M, Neerincx AH, et al. Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma. Biomedicines. 2023; 11: 676.

[35] Chen X, Wang K, Yao Q, Peng L, Wei L. The relationship between the rs4986791 variant of the TLR4 gene and the severity of bronchial asthma in children. Asian Pac J Allergy Immunol. 2024; 42: 159-64.

[36] Vieira MIR, Queiroz MVNP, Santana MBR, Silva HDS, Oliveira A, Figueiredo CAV, et al. The role of IL10 and IL17 gene polymorphisms in treatment response in children and adolescents with severe asthma. J Bras Pneumol. 2024; 49: e20230092.

[37] Deka H, Siddique MA, Ahmed SJ, Mahanta P, Mahanta P. Evaluation of IL-4 and IL-13 Single Nucleotide Polymorphisms and Their Association With Childhood Asthma and Its Severity: A Hospital-Based Case-Control Study. Cureus. 2024; 16: e57465.

[38] Licari A, Manti S, Castagnoli R, Leonardi S, Marseglia GL. Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice. Breathe (Sheff). 2020; 16: 190301.

[39] Andrenacci B, De Filippo M, Votto M, Prevedoni Gorone MS, De Amici M, La Grutta S, et al. Severe pediatric asthma endotypes: current limits and future perspectives. Expert Rev Respir Med. 2023; 17: 675-90.

[40] Choi BS. Eosinophils and childhood asthma. Clin Exp Pediatr. 2021; 64: 60-7.

[41] Kim CK, Callaway Z, Pawankar R. Eosinophil granule proteins as a biomarker in managing asthma and allergies. Asia Pac Allergy. 2023; 13: 66-71.

[42] Schepel IRM, Banzon TM, Phipatanakul W. Future of biologics in pediatric asthma: Optimizing response, early introduction, and equitable access to treatment. Ann Allergy Asthma Immunol. 2024; 132: 13-20.

[43] Wilson GE, Knight J, Liu Q, Shelar A, Stewart E, Wang X, et al. Activated sputum eosinophils associated with exacerbations in children on mepolizumab. J Allergy Clin Immunol. 2024; 154: 297-307.e13.

[44] Saxena S, Rosas-Salazar C, Fitzpatrick A, Bacharier LB. Biologics and severe asthma in children. Curr Opin Allergy Clin Immunol. 2023; 23: 111-8.

[45] Peláez G, Giubergia V, Lucero B, Aguerre V, Castaños C, Figueroa JM. Childhood severe asthma: relationship among asthma control scores, FeNO, spirometry and impulse oscillometry. BMC Pulm Med. 2024; 24: 270.

[46] Bacharier LB, Pavord ID, Maspero JF, Jackson DJ, Fiocchi AG, Mao X, et al. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. J Allergy Clin Immunol. 2024; 154: 101-10.

[47] Hatami H, Ghaffari N, Ghaffari J, Rafatpanah H. Role of Cytokines and Chemokines in the Outcome of Children With Severe Asthma. J Pediatr Rev. 2019; 7: 17-28.

[48] Martin Alonso A, Saglani S. Mechanisms Mediating Pediatric Severe Asthma and Potential Novel Therapies. Front Pediatr. 2017; 5: 154.

[49] Nagakumar P, Puttur F, Gregory LG, Denney L, Fleming L, Bush A, et al. Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids. Eur Respir J. 2019; 54: 1801809.

[50] Youness ER, Shady M, Nassar MS, Mostafa R, Abuelhamd W. The role of serum nuclear factor erythroid 2-related factor 2 in childhood bronchial asthma. J Asthma. 2020; 57: 347-52.

[51] Qin Q, Zhang X, Zhao X. Serum Biomarkers Predicting Airway Remodeling in Severe Childhood Bronchial Asthma. Altern Ther Health Med. 2024; 30: 158-63.

[52] Romejko K, Markowska M, Niemczyk S. The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int J Mol Sci. 2023; 24: 10470.

[53] Allam AA, Naguib MS, Hegazy MS, Fouad AM, Yehia S, Morad EA. Assessment of The Role of Serum Neutrophil Gelatinase-Associated Lipocalin in Egyptian Childhood Bronchial Asthma: One Centre Study. Egypt J Immunol. 2020; 27: 93-9.

[54] Kim MJ, Kim SY, Kim JD, Park M, Kim YH, Kim KW, et al. Release of sputum neutrophil granules is associated with pulmonary function and disease severity in childhood asthma. BMC Pulm Med. 2024; 24: 532.

[55] Di Cicco M, Ghezzi M, Kantar A, Song WJ, Bush A, Peroni D, et al. Pediatric obesity and severe asthma: Targeting pathways driving inflammation. Pharmacol Res. 2023; 188: 106658.

[56] Gaffin JM, Petty CR, Sorkness RL, Denlinger LC, Phillips BR, Ly NP, et al. National Heart, Lung; and Blood Institute’s Severe Asthma Research Program-3 Investigators. Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3. J Allergy Clin Immunol. 2023; 151: 138-46.e9.

[57] de Gouveia Belinelo P, Nielsen A, Goddard B, Platt L, Da Silva Sena CR, Robinson PD, et al. Clinical and lung function outcomes in a cohort of children with severe asthma. BMC Pulm Med. 2020; 20: 66.

[58] Coverstone AM, Bacharier LB, Wilson BS, Fitzpatrick AM, Teague WG, Phipatanakul W, et al. Clinical significance of the bronchodilator response in children with severe asthma. Pediatr Pulmonol. 2019; 54: 1694-703.

[59] Nuttall AG, Beardsmore CS, Gaillard EA. Ventilation heterogeneity in children with severe asthma. Eur J Pediatr. 2021; 180: 3399-404.

[60] Irving S, Fleming L, Ahmad F, Biggart E, Bingham Y, Cook J, et al. Lung clearance index and steroid response in pediatric severe asthma. Pediatr Pulmonol. 2020; 55: 890-8.

[61] Fain SB, McIntosh MJ. A new approach to computed tomography measurement of airway remodelling in paediatric asthma. ERJ Open Res. 2024; 10: 00763-2023.

[62] Lo D, Maniyar A, Gupta S, Gaillard E. High prevalence of bronchiectasis on chest CT in a selected cohort of children with severe Asthma. BMC Pulm Med. 2019; 19: 136.

[63] Silva TKBd, Zanon M, Altmayer S, Pacini GS, Watte G, Stein R, et al. High-resolution CT pulmonary findings in children with severe asthma. J Pediatr (Rio J). 2021; 97: 37-43.

[64] De Filippo M, Fasola S, De Matteis F, Gorone MSP, Preda L, Votto M, et al. Machine learning-enhanced HRCT analysis for diagnosis and severity assessment in pediatric asthma. Pediatr Pulmonol. 2024; 59: 3268-77.

[65] van den Bosch WB, Lv Q, Andrinopoulou ER, Pijnenburg MWH, Ciet P, Janssens HM, et al. Children with severe asthma have substantial structural airway changes on computed tomography. ERJ Open Res. 2024; 10: 00121-2023.

[66] van den Bosch WB, Ruijgrok EJ, Tousi NM, Tiddens HAWM, Janssens HM. Small Airways Disease Affects Aerosol Deposition in Children with Severe Asthma: A Functional Respiratory Imaging Study. J Aerosol Med Pulm Drug Deliv. 2024; 37: 351-61.

[67] Lin NY, Roach DJ, Willmering MM, Walkup LL, Hossain MM, Desirazu P, et al. ¹²⁹Xe MRI as a measure of clinical disease severity for pediatric asthma . J Allergy Clin Immunol. 2021; 147: 2146-53.e1.

[68] Safavi S, Munidasa S, Zanette B, Dai R, Stirrat E, Li D, et al. Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study. Respir Med. 2021; 180: 106368.

[69] Januska MN, Goldman DL, Webley W, Teague WG, Cohen RT, Bunyavanich S, et al. Bronchoscopy in severe childhood asthma: Irresponsible or irreplaceable? Pediatr Pulmonol. 2020; 55: 795-802.

[70] Nayir Büyükşahin H, Emiralioğlu N, Ademhan Tural D, Özsezen B, Sunman B, Güzelkaş İ, et al. The Importance of Flexible Bronchoscopy in Difficult-to-treat Asthma from a Pediatric Pulmonology Perspective. Turk Arch Pediatr. 2022; 57: 310-5.

[71] Ben Tkhayat R, Taytard J, Corvol H, Berdah L, Prévost B, Just J, et al. Benefits and risks of bronchoalveolar lavage in severe asthma in children. ERJ Open Res. 2021; 7: 00332-2021.

[72] Teague WG, Lawrence MG, Shirley DT, Garrod AS, Early SV, Payne JB, et al. Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma. J Allergy Clin Immunol Pract. 2019; 7: 1803-12.e10.

[73] Grunwell JR, Stephenson ST, Tirouvanziam R, Brown LAS, Brown MR, Fitzpatrick AM. Children with Neutrophil-Predominant Severe Asthma Have Proinflammatory Neutrophils With Enhanced Survival and Impaired Clearance. J Allergy Clin Immunol Pract. 2019; 7: 516-25.e6.

[74] Steinke JW, Lawrence MG, Teague WG, Braciale TJ, Patrie JT, Borish L. Bronchoalveolar lavage cytokine patterns in children with severe neutrophilic and paucigranulocytic asthma. J Allergy Clin Immunol. 2021; 147: 686-93.e3.

[75] Eller MCN, Pierantozzi Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, de Brito JM, Antonangelo L, et al. Bronchial eosinophils, neutrophils, and CD8 + T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma. Respir Res. 2022; 23: 335.

[76] Chorvinsky E, Nino G, Salka K, Gaviria S, Gutierrez MJ, Pillai DK. TSLP bronchoalveolar lavage levels at baseline are linked to clinical disease severity and reduced lung function in children with asthma. Front Pediatr. 2022; 10: 971073.